News

Forty-five percent of companies that have invested in serialization methods have seen over 31% increase in sales due to serialization

Partnership with Thoughtworks expected to increase transparency, streamline processes

Easing of Omicron restrictions in China played a role, association notes

The EPCIS communications standard is “recommended,” and trading partners are identified

Will benefit CDMO’s Denmark and Texas locations

New company targets data analytics based on a vast trove of patient health information

With a cost of approximately $514 million, expected completion is 2026

Cheshire facility will offer plasmid DNA production, CGT development

ParcelShield Intelligent Tracking and Planning Solution is designed to prevent parcel delays before shipping

Marks the CDMO’s second plant in the country

The latest people news happenings over the past month

Companies hope to combine their cryogenic expertise with dedicated packaging and supply chain services

Containers to potentially be operational by next year, 2024 at the latest

CDMO looks to combat cancer at lower doses

Agency will be reviewing laboratory study and CMC data on the bivalent jab that targets two strains of the SARS-CoV-2 virus

Features an ATP solution to allow for efficiency

CDMO’s Costa Mesa location can start tackling oncology and rare disease treatment

Partnership aims to compare reproducibility and comparability between different suspension bioreactors

New Garner, NC location will be its first outside the Midwest

Endeavor aims to tackle diversity obstacles surrounding this segment, while improving the patient experience

Focus on operational excellence is playing a major role in this effort, company says

CDMO’s Ireland campus will increase in capacity by 50% as a result

Expanded partnership revolves around hemophilia A therapeutics

Configurable applications address patient and healthcare-provider interfaces, and an analytics dashboard

Will serve as a hub, as company aims for growth in the European region

GMP facility allows for an increase in AAV vector production

Dominance of a handful of integrated firms “at the center of the US pharmaceutical system,” plus their trade practices, will be reviewed

Transaction totals about $3 billion